Antibiotics GE23077, Novel inhibitors of bacterial RNA polymerase II. Structure elucidation

9Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

During the screening program for new antibacterial agents produced by actinomycetes, GE23077 was isolated from fermentation broths of an Actinomadura sp. strain as a complex of factors A1, A2, B1, B2. NMR, MS and GC/MS analysis carried out on the isolated components led to the conclusion that GE23077 is a novel cyclic heptapeptide consisting of common and unusual amino acids. The chemical structures of the complex components were elucidated. Components A and B differ in the structure of the acyl group connected to a 2,3-diaminopropanoic acid moiety. A α-amino-malonic acid residue in the peptidic sequence is the origin of an isomerization process between A1 and A2 as well as B1 and B2. The chirality of the α-amino-malonic acid residue can be inverted easily via keto-enol tautomerism. Factors A2 and B2 should be considered as epimers of A1 and B1 respectively. By degradation studies the absolute configuration of some amino acids were determined. Chiral GC-MS and Micellar Electrokinetic Capillary Chromatography (MEKC) were used to define the absolute stereochemistries of five out often chiral centers. © Japan Antibiotics Research Association.

Cite

CITATION STYLE

APA

Marazzi, A., Kurz, M., Stefanelli, S., & Colombo, L. (2005). Antibiotics GE23077, Novel inhibitors of bacterial RNA polymerase II. Structure elucidation. Journal of Antibiotics, 58(4), 260–267. https://doi.org/10.1038/ja.2005.30

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free